Alves, Paula Maria Marques Leal Sanches
Alves, Paula M.
Alves, Paula
Paula Marques Alves biotecnóloga portuguesa
VIAF ID: 98588322 ( Personal )
Permalink: http://viaf.org/viaf/98588322
Preferred Forms
- 100 1 _ ‡a Alves, Paula
- 100 1 _ ‡a Alves, Paula M.
-
- 100 1 _ ‡a Alves, Paula Maria Marques Leal Sanches
-
- 100 0 _ ‡a Paula Marques Alves ‡c biotecnóloga portuguesa
4xx's: Alternate Name Forms (8)
Works
Title | Sources |
---|---|
Adenovirus as a biopharmaceutical optimisation of vector production | |
Advancing liver-stage malaria in vitro models for drug discovery | |
Bioprocess design of canine adenovirus vectors for gene therapy applications | |
Development of a vaccine candidate against heartwater producing obligate intracellular bacteria for veterinary application | |
Development of advance monitoring and control tools for rAAV production in insect cell system | |
Development of process technologies for the valorisation of fish and sellfish processing waste streams integration of sub and supercritical fluids with deep eutectic systems | |
Disclosing carbon monoxide protection in cerebral ischemia insight into the cellular mechanisms | |
Engineering human in vitro cardiac tissue models for preclinical research | |
Establishment and evaluation of flexible insect cell lines for rapid production of recombinant proteins | |
Expression of antibodies and retroviral vectors from defined chromosomal sites strategies towards reliable production systems | |
Host and immune responses to natural and experimental rotavirus infection | |
In vitro models for metabolic studies of brain insults | |
Leveraging single-cell analysis and genetic engineering to enhance recombinat AAV production in insect cells | |
Metabolism of 3-¹³C-malate in primary cultures of mouse astrocytes | |
NMR studies of central metabolism in brain cells immobilized primary cultures as a model-system | |
Novel approaches for culturing hepatocytes for drug testing applications | |
Novel cell models to study breast tumour microenvironment and disease progression | |
Novel cryopreservation strategies for cell-therapies and pre-clinical research | |
Portugal : drawing the world | |
Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009 | |
Process engineering of stem cells for clinical application | |
Rational design of insect cell-based vaccine production | |
Single-cell RNA sequencing for deciphering key biological mechanisms of insect cells during influenza HA-VLPs production | |
Stem cell bioprocessing strategies for cardiac regeneration unveilling CCBE1 role as a modulator of cardiomyocyte differentiation | |
Strategies for improved adenovirus and PPR vaccine production in different cell lines from bioprocess development to final formulation | |
Structurally primed phage-display librairies | |
Systems biotechnology of baculovirus-producing insect cells | |
Targeting cancer vulnerabilities from molecular targets to antitumor immunity | |
Towards novel stem cell and protein based therapies for myocardium regeneration exploiting myocardial ischemia-reperfusion models and advanced proteomic tools | |
Triple-layered rotavirus-like particles production focus on in vitro assembly and disassembly | |
Viral and cell host factors influencing the development of an HCV vaccine candidate |